Stock Screener App

Frei -

Installieren

4.40

3.51% -0.16

after-market

Handel nachbörslich: 4.40

Cytomx Therapeutics Inc (CTMX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Cytomx Therapeutics Inc-Aktie (CTMX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-06-30	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	68.04% 5.963	18.66	50.92	25.11	33.43
Operating Expenses	8.96% 21.73	19.94	28.30	33.57	29.32
Benefits Costs and Expenses	7.39% 20.13	18.75	27.33	31.60	27.64
Costs And Expenses	7.39% 20.13	18.75	27.33	31.60	27.64
Operating Income/Loss	1,126% -15.77	-1.286	22.62	-8.452	4.111
Income/Loss From Continuing Operations Before Tax	15,473% -14.17	-0.091	23.59	-6.483	5.797
Income Tax Expense/Benefit	7.94% 0.058	0.063	0.062	0.051	0.061
Income/Loss From Continuing Operations After Tax	9,140% -14.23	-0.154	23.52	-6.534	5.736
Net Income/Loss	9,140% -14.23	-0.154	23.52	-6.534	5.736
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	27.84% 165.00	129.08	87.12	84.88	85.09
Diluted Average Shares	27.84% 165.00	129.08	87.15	84.88	85.20
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

MRNA

$48.77

0.87%

ROIV

$27.88

1.59%

RPRX

$47.32

2.57%

BNTX

$91.28

0.11%

ONC

$302.49

2.67%

INSM

$163.81

0.85%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters